Facial Pain
35
2
4
17
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.6%
3 terminated out of 35 trials
85.0%
-1.5% vs benchmark
9%
3 trials in Phase 3/4
24%
4 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (35)
Feasibility Testing of the "Face-Forward-Web" Program for Chronic Orofacial Pain
SinuSonic for ETD and Facial Pain: Acoustic Vibration + Oscillating Expiratory Pressure
Efficacy of Combining Low-Level Laser Therapy With a Self-Management Program on Myalgia in Temporomandibular Disorders
Treatment of Atypical Resistant Facial Pain
Treatment of Sinus Headache Using a Novel Device That Combines Acoustic Vibration With Oscillating Expiratory Pressure
Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular Conflict
Comparison of Lidocaine, Mepivacaine, and Dry Needling in Myofascial Pain Syndrome
Effects of Photobiomodulation With Superpulsed Laser and Dual Wavelengths in Children and Adolescents
Erenumab for Idiosyncratic Facial Pain
MRI & QST Analysis in Trigeminal Neuralgia and Persistent Idiopathic Facial Pain
Emotion and Memory in Chronic Neuropathic Pain
Phenotype and Burden of a Midfacial Segment Pain
Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial)
Physical Exercises for Temporomandibular Disorders
Clinical Trial of Wireless CranioFacial Nerve Stimulation (CFNS) for the Treatment of CranioFacial Neuropathic Pain
Incidence of Intravascular (IV) Injection During Trigeminal Nerve Blocks
Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures
Proprioceptive Treatment for Temporomandibular Dysfunction
Stabilization Splint Treatment of TMD
Botox Injections for Patients With Persistent Facial Pain